People

Services

Industries

Firm

About

Knowledge

Careers

News

Events

Contact

Connect

Privacy Policy

Disclaimer

Terms of Use

Accessibility

Payments

Legal

Calgary

Toronto

Edmonton

Ottawa

Vancouver

New York

Montréal

Munaf Mohamed KC

Commercial Litigation & Economic Crimes Lawyer | Trials & Appeals

Partner

Brynne Harding

Litigation Lawyer at Bennett Jones Calgary

A bold Alberta Court of King's Bench decision, <a rel="noopener noreferrer" rel="noopener noreferrer" href="https://www.canlii.org/en/ab/abkb/doc/2023/2023abkb209/2023abkb209.html?" target="_blank">Alberta Health Services v Johnston, </a><a rel="noopener noreferrer" rel="noopener noreferrer" href="https://www.canlii.org/en/ab/abkb/doc/2023/2023abkb209/2023abkb209.html?" target="_blank">2023 ABKB 209</a>, declined to follow Ontario appellate authority on the issue and established the tort of harassment in Alberta to fill a "gap in the law".

Alberta Gains New Tort of Harassment and Limits Defamation By Government Actors

Alberta Gains New Tort of Harassment and Limits Defamation By Government Actors—Online and IRL

Justin R. Lambert

Securities & Commercial Litigator | Fraud & Energy Disputes

Michael D. Mysak KC

Corporate & Commercial Litigation Lawyer

In Henenghaixin Corp v Deng, 2022 ABCA 271, the Alberta Court of Appeal sent a clear warning that counsel applying for extraordinary remedies must be careful when relying on hearsay evidence to ground their claims. In this case, the applicants relied on hearsay evidence without explaining why they were required to do so. The result was that the order was set aside on appeal.

Is it Getting Harder to Get a Worldwide Freezing Injunction in Alberta

Is It Getting Harder to Get a Worldwide Freezing Injunction In Alberta?

Gary S.A. Solway

Technology, Media & Corporate Lawyer | Governance

John M. Mercury

Executive Chair & M&A Lawyer | Cross-Border Transactions

Executive Chair & Chair of the Board

Gary Solway, Munaf Mohamed, John Mercury, Michael Mysak and Paul Romaniuk write "Ten Takeaways for Buyers and Sellers in Private M&A Transactions" in CVCA Central.

Ten Takeaways for Buyers and Sellers in Private MA Transactions

Ten Takeaways for Buyers and Sellers in Private M&A Transactions

A private M&A purchase agreement customarily includes extensive representations and warranties and indemnification provisions. Post-closing, if the buyer alleges a breach of those provisions claiming significant damages, and the seller disputes that allegation, that dispute could end up before the courts for resolution.

Ten Takeaways for Private MA Sellers and Buyers in Canada from Recent Court Decision

Ten Takeaways for Private M&A Sellers and Buyers in Canada from Recent Court Decision

Serge Dupont

Senior Advisor at Bennett Jones Ottawa

Senior Advisor

Policy and business leaders in 2026 are confronting disruptive global forces that pose daunting economic and financial risks while also transforming markets and creating avenues for growth over the next years.

Economic Outlook Mid Year 2026

A Changing World: New Risks, New Opportunities

2026 Mid-Year Economic Outlook

Alison G. FitzGerald

International Arbitration Lawyer at Bennett Jones Ottawa

Nasra Moumin

Commercial Litigation Lawyer at Bennett Jones Toronto

Associate

Global trade policy is rapidly reshaping the regulatory and commercial landscape for life sciences companies. This update explores how evolving US tariff measures, national security reviews, CUSMA renewal uncertainty and expanding export controls are affecting pharmaceutical and medical device manufacturers operating across borders. The authors also examine Canada&rsquo;s response and the growing compliance, supply chain and market access challenges facing the sector in 2026 and beyond.

The Impact of Global Trade on the Life Sciences Sector

Vincent M. de Grandpré

IP Lawyer | Life Sciences & Tech

Melissa M. Dimilta

Intellectual Property Lawyer at Bennett Jones Toronto

Partner, Trademark Agent

As part of a deeply interconnected global sector, the life sciences industry in Canada is undergoing significant change alongside broad macroeconomic and geopolitical shifts.&nbsp;The Bennett Jones Life Sciences team looks at the top issues and developments affecting the industry in 2026.

2026 Life Sciences outlook

Legal and Market Trends to Watch This Year

Life Sciences Outlook 2026

Emily P. Kettel

Cross-border collaborations are central to the life sciences industry, but they can also raise complex questions about patent infringement liability in Canada. This update examines the Federal Court&rsquo;s recent decision in Adeia Guides Inc v Videotron Ltd and its implications for companies involved in the development, supply and commercialization of patented products and services. The authors explore how Canadian law approaches common design infringement, experimental use exemptions and the potential liability of foreign partners whose activities contribute to products ultimately sold in Canada.

Life Sciences Collaborations and the Risk of Joint Patent Infringement

Aaron E. Sonshine

Corporate Finance, Mergers and Acquisitions and Corporate Governance Lawyer at Bennett Jones Toronto

Partner 

The life sciences sector is experiencing a renewed wave of M&amp;A activity driven by patent expiries, expanding investor appetite and growing demand for innovative therapies and technologies. Drawing on insights shared at the Bloom Burton &amp; Co. Healthcare Investor Conference, this update explores the key trends shaping dealmaking in Canada and globally, including increased competition for assets, rising private transactions and growing investment in emerging markets such as China. The author also examines why current market conditions point to continued momentum across the sector in the second half of 2026.

Fraud, Asset Tracing & Recovery

From the Same Authors